About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristant #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Court Report | Main | Data Exclusivity Follow-up: More of the Same »

January 17, 2010

Comments


Voice your support for new Obama Health care plan at http://www.obamahealthcareplan.org

Join the conversation about the Obama Health care plan at http://www.obamahealthcareplan.org

It's a lousy bill ! The real shame is if it passes. America can do better than this. It's NOT ABOUT DEMS., POLITICAL CAPITAL, etc.; it's about appropriate healthcare! Missing the point completely seems to be the objective of all this healthcare hoopla

Kevin,

Having seen with wry amusement (and outrage) the "Louisiana Purchase" and "Cornhusker Deal" in this health care legislation, nothing surprises me anymore, including this latest effort to reduce the data exclusivity period for biosimilars. What is astounding is the political stupidity of the Democrat party in Congress and the White House that continues to push for unpopular legislation, yet is willing to commit "legislative suicide" over an issue as minor (at least to the general public) as the length of data exclusivity for biosimilars. As you suggest, Waxman and Obama would do better to get in the current biosimilar proposal and then work later on what the the length of data exclusivity should be. This "all or nothing approach" is simply arrogance, and is an attitude that is going to have consequences for the Democratic party this fall and beyond.

Very amusing. The hip biotechers sign on for the cruise but find their idol bumping them to steerage. A classic DC rope-a-dope trick and true Chicago-style politics. Pharma has participated in this grotesque corruption and they deserve what they (don't) get. And as far as Eshoo is concerned, too bad she didn't know the old rule about not to publicly asking a question you don't already know the answer to. She made the mistake the whole country has: We all assumed Obama was on our side.

The comments to this entry are closed.

June 2019

Sun Mon Tue Wed Thu Fri Sat
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30